Want to see AVTR full AI Analyst Report?
AVTR Stock Chart & Stats
$14.61
$0.32(2.80%)
At close: 4:00 PM EDT
$14.61
$0.32(2.80%)
Day’s Range― - ―
52-Week Range$7.27 - $17.33
Previous CloseN/A
Volume16.50M
Average Volume (3M)9.25M
Market Cap
$11.24B
Enterprise Value$10.10B
Total Cash (Recent Filing)$306.80M
Total Debt (Recent Filing)$3.70B
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Oct 28, 2026EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.84
Shares Outstanding676,358,800
10 Day Avg. Volume9,702,092
30 Day Avg. Volume9,247,394
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.40
Price to Sales (P/S)1.19
P/FCF Ratio15.70
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue1.54
Enterprise Value/Gross Profit4.83
Enterprise Value/Ebitda80.57
Forecast
1Y Price Target
$14.96Price Target Upside2.38% Upside
Rating ConsensusHold
Number of Analyst Covering13
EPS Forecast (FY)0.81
Revenue Forecast (FY)$6.59B
Bulls Say, Bears Say
Bulls Say
Mission-Critical Recurring DemandAvantor’s recurring consumables and mission-critical bioprocessing offerings support repeat purchasing as customers continue research and manufacturing. Qualification requirements, switching costs, and managed procurement relationships can deepen customer integration and provide durable revenue visibility.
Positive Cash GenerationPositive operating and free cash flow provides internal funding for investment, debt reduction, and ongoing operations despite reported net losses. Although cash generation has weakened, its continued presence offers financial support while management works to restore profitability.
Operational Improvement And GuidanceMeasured gains from the Revival program indicate that operational changes are improving throughput and customer onboarding efficiency. These process improvements can support execution, reduce friction across the commercial platform, and strengthen the company’s ability to convert demand into profitable growth.
Bears Say
Sustained Profitability DeteriorationThe shift from solid profitability in 2022–2024 to substantial net and operating losses weakens earnings quality and reduces the company’s ability to fund growth from profits. Gross-margin pressure and expense load could remain a material drag until profitability sustainably recovers.
BMP Revenue And Order HeadwindsBMP’s organic decline and identified headwinds in electronic materials create a meaningful drag on consolidated growth over the coming quarters. Continued normalization in Serum and Electronic Materials, alongside weakness in Fluid Handling and NuSil, could delay a broad-based recovery.
Leverage Above TargetLeverage remains above management’s stated target despite substantial recent debt repayment, leaving less balance-sheet flexibility than intended. Continued deleveraging may compete with investment and other capital-allocation priorities, particularly while earnings and free cash flow are under pressure.
Avantor News
AVTR FAQ
What was Avantor Inc’s price range in the past 12 months?
Avantor Inc lowest stock price was $7.26 and its highest was $17.33 in the past 12 months.
What is Avantor Inc’s market cap?
Avantor Inc’s market cap is $11.24B.
When is Avantor Inc’s upcoming earnings report date?
Avantor Inc’s upcoming earnings report date is Oct 28, 2026 which is in 6 days.
How were Avantor Inc’s earnings last quarter?
Avantor Inc released its earnings results on Jul 29, 2026. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.192 by $0.018.
Is Avantor Inc overvalued?
According to Wall Street analysts Avantor Inc’s price is currently Undervalued.
Does Avantor Inc pay dividends?
Avantor Inc does not currently pay dividends.
What is Avantor Inc’s EPS estimate?
Avantor Inc’s EPS estimate is 0.21.
How many shares outstanding does Avantor Inc have?
Avantor Inc has 676,358,800 shares outstanding.
What happened to Avantor Inc’s price movement after its last earnings report?
Avantor Inc reported an EPS of $0.21 in its last earnings report, beating expectations of $0.192. Following the earnings report the stock price went up 15.781%.
Which hedge fund is a major shareholder of Avantor Inc?
Currently, no hedge funds are holding shares in AVTR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Avantor Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.96 (2.38% Upside)
$14.96 (2.38% Upside)
Blogger Sentiment
Neutral
AVTR Sentiment 60%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 5.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 10.7%
Last 30 Days ▲ 10.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.48%
12-Months-Change
Fundamentals
Return on Equity
-10.34%
Trailing 12-Months
Asset Growth
-9.24%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Avantor Inc
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
AVTR Company Deck
AVTR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed tangible operational progress and improving commercial momentum, highlighted by VWR's return to organic growth, strong free cash flow generation, measurable Revival-driven productivity gains, and raised full-year guidance. These positives are balanced against near-term headwinds in the BMP segment from discrete order normalization, ongoing inflationary and FX pressures, and leverage that remains above the company's target. Management expressed confidence in accelerating growth into the second half and into 2027, supported by order momentum and execution improvements.View all AVTR earnings summariesAVTR Net sales Breakdown
58.44% Americas
34.74% Europe
6.82% AMEA
AVTR Stock 12 Month Forecast
Average Price Target
$14.96
▲(2.38% Upside)
Technical Analysis
Ownership Overview
0.65% Insiders
40.90% Mutual Funds
0.44% Other Institutional Investors
36.80% Public Companies and
Individual Investors